Healthcare deal delays persist
Healthcare declined 13.1% QoQ due to deals slipping from Q4 to Q1; if closures continue to delay, recovery may be pushed further.
high · management_commentaryTata Elxsi reported Q4 FY26 revenue of ₹993.8 crore, growing 0.9% QoQ in constant currency, with EBITDA margin improving 130 bps sequentially to 24.6%.
Financial stats pending filing verification
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Healthcare declined 13.1% QoQ due to deals slipping from Q4 to Q1; if closures continue to delay, recovery may be pushed further.
high · management_commentaryManagement cited geopolitical tensions as a factor reducing visibility and pushing growth expectations to high single digits.
medium · management_commentaryAnalyst raised concern about AI deflation; management acknowledged some aggressive competitor pricing but said it's not widespread yet.
medium · analyst_questionManagement noted that 10-15% of revenue runs off every quarter due to project completions, requiring constant refilling of the funnel.
medium · data_observation